-

British health agency approves Alimta for mesothelioma asbestos cancer patients, reversing prior decision
After protests from asbestos cancer victims and patient advocates and an appeal by the drug’s manufacturer, Great Britain’s National Institute for Health and Clinical Excellence (NICE) has revised its position on the drug Alimta, approving it to treat mesothelioma, a cancer of the lining of the lungs.  NICE’s previous ruling had made the drug unavailable

After protests from asbestos cancer victims and patient advocates and an appeal by the drug’s manufacturer, Great Britain’s National Institute for Health and Clinical Excellence (NICE) has revised its position on the drug Alimta, approving it to treat http://info.cancerresearchuk.org/news/